Whilst GLP-1 receptor agonists slow the digestive process, there is no substantial evidence that they significantly impair nutrient absorption in individuals with normal pancreatic function
This helps lower blood sugar without typically causing hypoglycemia, which is why GLP-1 therapy can be used in both diabetic and some non-diabetic patients
How many treatments are needed
doi:10.1016/j.freeradbiomed.2013.05.019, PMID: 23707456 Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E (2011) Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis/chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression
Lisdexamfetamine (Vyvanse) remains the only FDA-approved medication for binge eating disorder
Despite these encouraging findings, further research is still needed to understand more thoroughly the mechanisms by which GLP-1RAs may mediate stroke protection specifically in the human diabetic brain